Freeline Therapeutics Holdings plc, a clinical-stage, fully integrated, next generation, systemic, AAV-based gene therapy company with the ambition of transforming the lives of patients suffering from inherited systemic debilitating diseases, announces that Romuald Corbau, Ph.D. has been promoted to the role of Chief Scientific Officer.
September 28, 2020
· 4 min read